Literature DB >> 28786050

Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.

Rong Lin1, Chao-Qun Han1, Wei-Jun Wang1, Jun Liu1, Wei Qian1, Zhen Ding2, Xiao-Hua Hou1.   

Abstract

Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR≤0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.

Entities:  

Keywords:  lymph node ratio; pancreatic adenocarcinoma; prognosis; survival

Mesh:

Substances:

Year:  2017        PMID: 28786050     DOI: 10.1007/s11596-017-1780-2

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  41 in total

1.  Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer.

Authors:  Di Zhou; Ming Ye; Yongrui Bai; Ling Rong; Yanli Hou
Journal:  Can J Surg       Date:  2015-08       Impact factor: 2.089

2.  Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer.

Authors:  Monica Dandona; David Linehan; William Hawkins; Steven Strasberg; Feng Gao; Andrea Wang-Gillam
Journal:  Pancreas       Date:  2011-08       Impact factor: 3.327

Review 3.  Surgery for pancreatic cancer: recent controversies and current practice.

Authors:  Curtis J Wray; Syed A Ahmad; Jeffrey B Matthews; Andrew M Lowy
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

Review 4.  Extended Versus Standard Lymphadenectomy for Pancreatic Head Cancer: Meta-Analysis of Randomized Controlled Trials.

Authors:  Bobby V M Dasari; Sandro Pasquali; Ravinder S Vohra; Andrew M Smith; Mark A Taylor; Robert P Sutcliffe; Paolo Muiesan; Keith J Roberts; John Isaac; Darius F Mirza
Journal:  J Gastrointest Surg       Date:  2015-06-09       Impact factor: 3.452

5.  Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.

Authors:  Sébastien Gaujoux; Javiera Torres; Sara Olson; Corrine Winston; Mithat Gonen; Murray F Brennan; David S Klimstra; Michael D'Angelica; Ronald DeMatteo; Yuman Fong; Michael House; William Jarnagin; Robert C Kurtz; Peter J Allen
Journal:  Ann Surg Oncol       Date:  2012-03-13       Impact factor: 5.344

6.  Prognostic factors in the palliation of pancreatic cancer.

Authors:  F J F Engelken; V Bettschart; M Q Rahman; R W Parks; O J Garden
Journal:  Eur J Surg Oncol       Date:  2003-05       Impact factor: 4.424

Review 7.  An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma.

Authors:  Alexander Stojadinovic; Ari Brooks; Axel Hoos; David P Jaques; Kevin C Conlon; Murray F Brennan
Journal:  J Am Coll Surg       Date:  2003-06       Impact factor: 6.113

8.  Extent of Lymphadenectomy and Prognosis After Esophageal Cancer Surgery.

Authors:  Jesper Lagergren; Fredrik Mattsson; Janine Zylstra; Fuju Chang; James Gossage; Robert Mason; Pernilla Lagergren; Andrew Davies
Journal:  JAMA Surg       Date:  2016-01       Impact factor: 14.766

9.  Lymph node evaluation for treatment of adenocarcinoma of the pancreas.

Authors:  Schelomo Marmor; Erin E Burke; Pamela R Portschy; Beth A Virnig; Eric H Jensen; Todd M Tuttle
Journal:  Surg Oncol       Date:  2015-08-07       Impact factor: 3.279

10.  Lymph Node Metastasis, a Unique Independent Prognostic Factor in Early Gastric Cancer.

Authors:  Bai-Wei Zhao; Yong-Ming Chen; Shan-Shan Jiang; Yin-Bo Chen; Zhi-Wei Zhou; Yuan-Fang Li
Journal:  PLoS One       Date:  2015-07-08       Impact factor: 3.240

View more
  4 in total

1.  Clinicopathologic characteristics, laboratory parameters, treatment protocols, and outcomes of pancreatic cancer: a retrospective cohort study of 1433 patients in China.

Authors:  Shuisheng Zhang; Xiaozhun Huang; Yuan Tian; Saderbieke Aimaiti; Jianwei Zhang; Jiuda Zhao; Yingtai Chen; Chengfeng Wang
Journal:  PeerJ       Date:  2018-05-28       Impact factor: 2.984

2.  Prognostic value of COL6A3 in pancreatic adenocarcinoma.

Authors:  Christos Svoronos; Georgios Tsoulfas; Maria Souvatzi; Efthimios Chatzitheoklitos
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2020-02-27

3.  Exploration of an effective training system for the diagnosis of pancreatobiliary diseases with EUS: A prospective study.

Authors:  Chaoqun Han; Chi Nie; Xiaoping Shen; Tao Xu; Jun Liu; Zhen Ding; Xiaohua Hou
Journal:  Endosc Ultrasound       Date:  2020 Sep-Oct       Impact factor: 5.628

4.  Prognostic Nomogram for Patients With Pancreatic Ductal Adenocarcinoma of Pancreatic Head After Pancreaticoduodenectomy.

Authors:  Hongkai Zhuang; Zixuan Zhou; Zuyi Ma; Shanzhou Huang; Yuanfeng Gong; Zhenchong Li; Chunsheng Liu; Shujie Wang; Bo Chen; Chuanzhao Zhang; Baohua Hou
Journal:  Clin Med Insights Oncol       Date:  2021-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.